IMAC Holdings, Inc. (BACK)
USD 0.04
(45.21%)
USD 0.04
(45.21%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 5.02 Million USD | -99.98% |
| 2022 | 24.52 Million USD | 8.01% |
| 2021 | 22.7 Million USD | 28.4% |
| 2020 | 17.68 Million USD | -5.79% |
| 2019 | 18.77 Million USD | 101.44% |
| 2018 | 9.31 Million USD | 468.94% |
| 2017 | 1.63 Million USD | 612.8% |
| 2016 | 229.78 Thousand USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 408.63 Thousand USD | 107.34% |
| 2023 Q1 | 4.08 Million USD | -26.96% |
| 2023 Q3 | 3.55 Million USD | 54.74% |
| 2023 Q2 | 2.29 Million USD | -43.78% |
| 2023 FY | 2.53 Million USD | -89.65% |
| 2023 Q4 | -5.56 Million USD | -256.73% |
| 2022 Q1 | 6.53 Million USD | 0.75% |
| 2022 Q4 | 5.58 Million USD | -6.89% |
| 2022 FY | 24.52 Million USD | 8.01% |
| 2022 Q3 | 6 Million USD | -6.24% |
| 2022 Q2 | 6.4 Million USD | -1.99% |
| 2021 Q4 | 6.48 Million USD | 9.63% |
| 2021 Q3 | 5.91 Million USD | 6.77% |
| 2021 FY | 22.7 Million USD | 28.4% |
| 2021 Q1 | 4.77 Million USD | 5.71% |
| 2021 Q2 | 5.53 Million USD | 16.06% |
| 2020 Q4 | 4.51 Million USD | 3.61% |
| 2020 FY | 17.68 Million USD | -5.79% |
| 2020 Q3 | 4.35 Million USD | 12.39% |
| 2020 Q1 | 4.93 Million USD | -3.4% |
| 2020 Q2 | 3.87 Million USD | -21.46% |
| 2019 Q2 | 4.76 Million USD | 29.66% |
| 2019 FY | 18.77 Million USD | 101.44% |
| 2019 Q4 | 5.1 Million USD | 1.32% |
| 2019 Q3 | 5.04 Million USD | 5.73% |
| 2019 Q1 | 3.67 Million USD | 2.12% |
| 2018 Q1 | 814.68 Thousand USD | 35.88% |
| 2018 FY | 9.31 Million USD | 468.94% |
| 2018 Q4 | 3.6 Million USD | 6.0% |
| 2018 Q3 | 3.39 Million USD | 125.94% |
| 2018 Q2 | 1.5 Million USD | 84.6% |
| 2017 Q1 | 17.34 Thousand USD | 0.0% |
| 2017 Q2 | 181.78 Thousand USD | 948.38% |
| 2017 Q3 | 436.03 Thousand USD | 139.85% |
| 2017 FY | 1.63 Million USD | 612.8% |
| 2017 Q4 | 599.54 Thousand USD | 37.5% |
| 2016 FY | 229.78 Thousand USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 176.01 Million USD | 97.144% |
| Addus HomeCare Corporation | 248.92 Million USD | 97.98% |
| AirSculpt Technologies, Inc. | 118.32 Million USD | 95.751% |
| Amedisys, Inc. | 834.47 Million USD | 99.398% |
| Astrana Health, Inc. | 112.59 Million USD | 95.535% |
| Aveanna Healthcare Holdings Inc. | 587.36 Million USD | 99.144% |
| biote Corp. | 98.82 Million USD | 94.913% |
| Cryo-Cell International, Inc. | 35.2 Million USD | 85.721% |
| Cross Country Healthcare, Inc. | 337.69 Million USD | 98.511% |
| COMPASS Pathways plc | 136.91 Million USD | 96.328% |
| DocGo Inc. | 180.32 Million USD | 97.212% |
| The Ensign Group, Inc. | 335.39 Million USD | 98.501% |
| Healthcare Services Group, Inc. | 189.09 Million USD | 97.341% |
| InnovAge Holding Corp. | 558.25 Million USD | 99.099% |
| The Joint Corp. | 109.22 Million USD | 95.397% |
| LifeStance Health Group, Inc. | 491.23 Million USD | 98.977% |
| Mobile-health Network Solutions Class A Ordinary Shares | 18.24 Million USD | 72.442% |
| ModivCare Inc. | 586.89 Million USD | 99.143% |
| NewGenIvf Group Limited | 1.63 Million USD | -206.618% |
| Option Care Health, Inc. | 666.62 Million USD | 99.246% |
| P3 Health Partners Inc. | 199.56 Million USD | 97.481% |
| P3 Health Partners Inc. | 199.56 Million USD | 97.481% |
| The Pennant Group, Inc. | 88.99 Million USD | 94.351% |
| Surgery Partners, Inc. | 319.5 Million USD | 98.427% |
| Syra Health Corp. Class A Common Stock | 4.29 Million USD | -16.924% |
| Talkspace, Inc. | 97.58 Million USD | 94.849% |
| Talkspace, Inc. | 97.58 Million USD | 94.849% |
| The Oncology Institute, Inc. | 136.59 Million USD | 96.32% |
| The Oncology Institute, Inc. | 136.59 Million USD | 96.32% |